Is radioiodine administration in patients with papillary thyroid multifocal microcarcinoma unnecessary?
Radioiodine (RAI) has played a crucial role in differentiated thyroid cancer treatment for more than 60years. However, the use of RAI administration in patients with papillary thyroid microcarcinoma (even multifocal) is now being widely discussed and often not recommended. In accordance with Europea...
Main Authors: | Eva Krčálová, Jiří Horáček, Lubomír Kudlej, Viera Rousková, Blanka Michlová, Irena Vyhnánková, Jiří Doležal, Jaroslav Malý, Pavel Žák |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2016-05-01
|
Series: | Endocrinology, Diabetes & Metabolism Case Reports |
Online Access: | https://www.edmcasereports.com/articles/endocrinology-diabetes-and-metabolism-case-reports/10.1530/EDM-15-0138 |
Similar Items
-
Salivary gland function in thyroid cancer patients with radioiodine administration history
by: Eva Krcalova, et al.
Published: (2020-09-01) -
Multifocality and Bilaterality of Papillary Thyroid Microcarcinoma
by: Yoon Kyoung So, et al.
Published: (2015-06-01) -
RADIOIODINE TREATMENT OF GRAVES’ DISEASE – DOSE/RESPONSE ANALYSIS
by: Jitka Čepková, et al.
Published: (2014-01-01) -
Multifocal papillary thyroid microcarcinoma in the end stage of Hashimoto’s thyroiditis
by: Kovačević Božidar, et al.
Published: (2018-01-01) -
Therapeutic Outcomes of Patients with Multifocal Papillary Thyroid Microcarcinomas and Larger Tumors
by: Soh-Ching Ng, et al.
Published: (2017-01-01)